Product Comparison

Comparison Options

• Print
• Email
• Export Compare

	No Image
McKesson #	1166153	706308
Description	Valrubicin 40 mg / mL Injection 5 mL	TICE® BCG Bacillus Calmette-Guérin (BCG) Live 50 mg Injection 2 mL
Manufacturer #	24201010104	00052060202
Brand		TICE® BCG
Manufacturer	Hikma Specialty USA (Leucadia)	Schering Plough
Invoice	VALRUBICIN, SDV 40MG/ML 5ML (4/CT)	TICE BCG, VL 50MG 2ML
	Log In to Order	Log In to Order
Comparison
Country of Origin	Unknown	United States
Generic Drug Code	94175	14103
Generic Drug Name	Valrubicin	Bacillus Calmette-Guérin (BCG) Live
NDC Number	24201010104	00052060202
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days
Strength	40 mg / mL	50 mg
UNSPSC Code	51281810	51201647
Volume	5 mL	2 mL
Application	Bladder Cancer Treatment	Bladder Cancer Treatment
Container Type	Single-Dose Vial	Single-Dose Vial
Dosage Form	Injection	Injection
Storage Requirements	Requires Refrigeration	Requires Refrigeration
Type	Intravesical	Intravesical
Features and Benefits	Do not administer without diluting For Intravesical use only Not for intramuscular or intravenous use	The dose for the intravesical treatment of carcinoma in situ and for the prophylaxis of recurrent papillary tumors consists of one vial of TICE® BCG suspended in 50 ml preservative-free saline Intravesical TICE® BCG has been used as a therapy for, and prophylaxis against, recurrent tumors in patients with carcinoma in situ (CIS) of the urinary bladder, and to prevent recurrence of Stage TaT1 papillary tumors of the bladder at high risk of recurrence BCG LIVE (TICE® BCG) is not a vaccine for the prevention of cancer Reconstituted TICE® BCG should be kept refrigerated (2-8° C), protected from exposure to direct sunlight, and used within 2 hours Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)